Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Autologous Stem Cells for Cerebral Palsy
NCT02231242Phase 2Unknown
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Sep 2013
- Primary completion
- Dec 2015
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous bone marrow total nucleated cells in cerebral palsy (CP) (2 arms), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Primary endpoint: Number of participants who show progress in GMFCS scale at 6 months. Status: unknown.
02
Drugs
autologous bone marrow total nucleated cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT02231242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02231242.